- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00997048
Comparison Between Laying Open and Sinus Excision of Pilonidal Sinus - a Randomized Study
October 15, 2009 updated by: Uppsala University
A pilonidal sinus is a cyst or abscess near or on the natal cleft of the buttocks that often contains hair and skin debris.
The condition is common and requires surgery to be cured.
Several surgical procedures are described in literature.
The most common surgical procedure in Sweden is excision of the sinus followed by suturing the subcutaneous tissue and skin.
This method, however, has some problems regarding healing and recidives.
Therefore this study is comparing the standard excision procedure to another surgical procedure, laying open.
Healing frequency is the main variable, but postoperative pain, sick leave time and patient satisfaction is also measured.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Uppsala, Sweden, 751 85
- Uppsala University Hospital, surgery
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Pilonidal sinus eligible for surgery
- Age > 18 years
- Swedish speaking
Exclusion Criteria:
- Active signs of infection prohibiting primary sewing of the wound
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Laying open
|
Laying open Antibiotics Dalacin 300 mg tablets or iv infusion 600 mg
|
|
ACTIVE_COMPARATOR: Sinus excision
|
Sinus excision Antibiotics Dalacin tablets 300 mg or iv infusion 600 mg
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Healing frequency
Time Frame: 12 months
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
pain according to a visual analogue scale
Time Frame: 7 days
|
7 days
|
|
scar/wound length
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Wilhelm Graf, MD, PhD, Uppsala University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2002
Primary Completion (ACTUAL)
March 1, 2006
Study Completion (ACTUAL)
March 1, 2006
Study Registration Dates
First Submitted
October 15, 2009
First Submitted That Met QC Criteria
October 15, 2009
First Posted (ESTIMATE)
October 16, 2009
Study Record Updates
Last Update Posted (ESTIMATE)
October 16, 2009
Last Update Submitted That Met QC Criteria
October 15, 2009
Last Verified
October 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EPN 2002/139
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.